R
Rocco Malivindi
Researcher at University of Calabria
Publications - 61
Citations - 1346
Rocco Malivindi is an academic researcher from University of Calabria. The author has contributed to research in topics: Aromatase & Receptor. The author has an hindex of 17, co-authored 51 publications receiving 1002 citations.
Papers
More filters
Journal ArticleDOI
Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
Stefania Catalano,Cinzia Giordano,Pietro Rizza,Guowei Gu,Ines Barone,Daniela Bonofiglio,Francesca Giordano,Rocco Malivindi,Donatella Gaccione,Marilena Lanzino,Francesca De Amicis,Sebastiano Andò +11 more
TL;DR: Results support the hypothesis that STAT3 and CREB play an important role in leptin signaling pathway that leads to the proliferation of Ishikawa cells, thus establishing a direct association between obesity and endometrial tumorogenesis.
Journal ArticleDOI
Myocytic androgen receptor controls the strength but not the mass of limb muscles
Céline Chambon,Delphine Duteil,Alban Vignaud,Arnaud Ferry,Nadia Messaddeq,Rocco Malivindi,Shigeaki Kato,Pierre Chambon,Daniel Metzger +8 more
TL;DR: Androgens control perineal and limb muscle mass in male mice through myocytic AR-dependent and -independent pathways, respectively, which may allow the design of screens to identify selective androgen modulators of muscle strength.
Journal ArticleDOI
Rapid Estradiol/ERα Signaling Enhances Aromatase Enzymatic Activity in Breast Cancer Cells
Stefania Catalano,Ines Barone,Cinzia Giordano,Pietro Rizza,Hongyan Qi,Guowei Gu,Rocco Malivindi,Daniela Bonofiglio,Sebastiano Andò +8 more
TL;DR: It is shown, for the first time, that tyrosine phosphorylation processes play a key role in the rapid changes induced by E2 in aromatase enzymatic activity, revealing the existence of a short nongenomic autocrine loop between E2 and aromat enzyme in breast cancer cells.
Journal ArticleDOI
Insulin-Like Growth Factor-I, Regulating Aromatase Expression through Steroidogenic Factor 1, Supports Estrogen-Dependent Tumor Leydig Cell Proliferation
Rosa Sirianni,Adele Chimento,Rocco Malivindi,Ignazio Mazzitelli,Sebastiano Andò,Vincenzo Pezzi +5 more
TL;DR: One of the molecular mechanisms determining Leydig cell tumorigenesis is an excessive estrogen production that stimulates a short autocrine loop determining cell proliferation.
Journal ArticleDOI
Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cells.
Stefania Catalano,Rocco Malivindi,Cinzia Giordano,Guowei Gu,Salvatore Panza,Daniela Bonofiglio,Marilena Lanzino,Diego Sisci,Maria Luisa Panno,Sebastiano Andò +9 more
TL;DR: It is found that FXR activation by the primary bile acid chenodeoxycholic acid or a synthetic agonist GW4064, through a SHP-independent mechanism, down-regulates aromatase expression in terms of mRNA, protein levels, and its enzymatic activity.